Thanks Foruno, we all need sanity checks and reassurance every once in while. Days like today get old seeing the bears being correct repeatedly and the share price depressed.

I'm not a scientist or biotech guru, but Leronlimab is very impressive. Having a financial background, the balance sheet is a little concerning, but I don't see any way they don't get to revenues at this point. Revenues (along with other successful indications) will change everything. I haven't lived paycheck-to-paycheck since college, but many people do and still survive and even thrive once they get better footing.